Dr. Voorzanger-Rousselot's research is focused on developing new biochemical markers of bone metastases in cancer. She graduated in human biology from University of Paris VI “Pierre et Marie Curie”. Prior to joining Synarc since 5 years in Research and Development, Dr. VOORZANGER-ROUSSELOT has worked at the “Centre Léon Bérard” cancer research institute, Lyon, France. She has authored scientific abstracts and articles focused on new prognostic factors in cancer.